Based on previous studies that indicate that anti-CEP-1 could help to identify ACPA-negative RA patients, we analyzed the reactivity of chimeric enolase peptides with the ACPA-seronegative RA sera (n = 51) from the 178 RA patients. The gene discussed is PRTN3; the disease is rheumatoid arthritis.